Organogenesis Holdings (ORGO) Profit After Tax (2016 - 2026)
Organogenesis Holdings' (ORGO) quarterly Profit After Tax came in at -$53.2 million in Q1 2026, down 182.1% year-on-year from $64.7 million in Q1 2025, and down 201.96% quarter-over-quarter from $52.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Profit After Tax (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Profit After Tax history runs 11 years deep, the most recent figure standing at -$53.2 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 182.1% year-over-year to -$53.2 million in Q1 2026; TTM through Mar 2026 was $11.2 million, a 170.21% increase from a year earlier, with the FY2025 full-year figure at $37.0 million, up 4201.05% from the prior year.
- Profit After Tax eased to -$53.2 million in Q1 2026 per ORGO's latest filing, from $52.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $52.1 million in Q4 2025 and bottomed at -$53.2 million in Q1 2026.
- The 5-year median for Profit After Tax is $215000.0 (2022), against an average of $802764.7.
- Across the five-year window, Profit After Tax jumped 1450.88% in 2024 and plunged 797.29% in 2025, its largest moves.
- Year by year, Profit After Tax stood at $7.5 million in 2022, then sank by 107.59% to -$568000.0 in 2023, then soared by 1450.88% to $7.7 million in 2024, then surged by 579.42% to $52.1 million in 2025, then tumbled by 201.96% to -$53.2 million in 2026.
- Per Business Quant, the three latest ORGO Profit After Tax figures stand at -$53.2 million (Q1 2026), $52.1 million (Q4 2025), and $21.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | -53.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.16 Mn |
| Dec 31, 2025 | 52.13 Mn |
| Sep 30, 2025 | 21.57 Mn |
| Jun 30, 2025 | -9.39 Mn |
| Mar 31, 2025 | -18.84 Mn |
| Dec 31, 2024 | 7.67 Mn |
| Sep 30, 2024 | 12.33 Mn |
| Jun 30, 2024 | -17.04 Mn |
| Mar 31, 2024 | -2.10 Mn |
| Dec 31, 2023 | -568,000.00 |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 5.32 Mn |
| Mar 31, 2023 | -2.97 Mn |
| Dec 31, 2022 | 7.49 Mn |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 8.74 Mn |
| Mar 31, 2022 | -913,000.00 |
| Dec 31, 2021 | 51.00 Mn |
| Sep 30, 2021 | 12.58 Mn |
| Jun 30, 2021 | 20.69 Mn |